Risk of Alzheimer's Disease and Related Dementias in Persons with Glaucoma: A National Cohort Study
- PMID: 37839560
- DOI: 10.1016/j.ophtha.2023.10.014
Risk of Alzheimer's Disease and Related Dementias in Persons with Glaucoma: A National Cohort Study
Abstract
Purpose: Glaucoma is a heterogeneous group of optic neuropathies that potentially may be associated with other cerebral neurodegenerative processes leading to dementia. However, prior studies have been inconsistent. We examined dementia risks after glaucoma diagnosis in a large population-based cohort.
Design: National matched cohort study.
Participants: A total of 324 730 persons diagnosed with glaucoma during 1995-2017 in Sweden and 3 247 300 age- and sex-matched population-based controls without prior dementia.
Methods: Cox regression was used to compute hazard ratios (HRs) for Alzheimer's disease (AD), vascular dementia (VaD), and all-cause dementia in persons with glaucoma compared with controls, adjusting for sociodemographic factors and comorbidities.
Main outcome measures: Alzheimer's disease, VaD, and all-cause dementia identified from nationwide inpatient and outpatient diagnoses through 2018.
Results: In 16 million person-years of follow-up, 32 339 persons (10%) with glaucoma and 226 896 controls (7%) were diagnosed with dementia. Persons with glaucoma had increased risks for AD (adjusted HR, 1.39; 95% confidence interval [CI], 1.35-1.43), VaD (1.66; 1.61-1.72), and all-cause dementia (1.57; 1.54-1.59). Among glaucoma subtypes, both primary open-angle and normal-tension glaucoma were associated with increased risk for AD (adjusted HR, 1.31; 95% CI, 1.27-1.36; and 1.28; 1.20-1.36, respectively) and VaD (1.61; 1.54-1.68; and 1.39; 1.28-1.50, respectively), whereas primary angle-closure glaucoma was associated with VaD (1.26; 1.02-1.56) but not AD (0.98; 0.82-1.18). These findings were similar in men and women. All risks were highest in persons diagnosed with glaucoma at ages ≥ 70 years and were not elevated for ages < 60 years.
Conclusions: In this large national cohort, persons with glaucoma had increased risks for AD, VaD, and all-cause dementia, particularly those diagnosed with glaucoma at older ages. Persons with glaucoma may need increased monitoring for dementia to facilitate earlier detection and treatment.
Financial disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Keywords: Alzheimer disease; Dementia; Glaucoma; vascular.
Copyright © 2023 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Early-Onset Ocular Motor Cranial Neuropathy Is a Strong Predictor of Dementia: A Nationwide, Population-Based Cohort Study.Ophthalmology. 2024 Mar;131(3):288-301. doi: 10.1016/j.ophtha.2023.10.006. Epub 2023 Oct 12. Ophthalmology. 2024. PMID: 37832727
-
Risk of depression in persons with Alzheimer's disease: A national cohort study.Alzheimers Dement (Amst). 2024 Apr 14;16(2):e12584. doi: 10.1002/dad2.12584. eCollection 2024 Apr-Jun. Alzheimers Dement (Amst). 2024. PMID: 38623385 Free PMC article.
-
Associations between primary open angle glaucoma, Alzheimer's disease and vascular dementia: record linkage study.Br J Ophthalmol. 2015 Apr;99(4):524-7. doi: 10.1136/bjophthalmol-2014-305863. Epub 2014 Nov 4. Br J Ophthalmol. 2015. PMID: 25370081
-
Public health importance of vascular dementia and Alzheimer's disease with cerebrovascular disease.Int J Clin Pract Suppl. 2001 May;(120):41-8. Int J Clin Pract Suppl. 2001. PMID: 11406925 Review.
-
The Association Between Eye Disease and Incidence of Dementia: Systematic Review and Meta-Analysis.J Am Med Dir Assoc. 2023 Sep;24(9):1363-1373.e6. doi: 10.1016/j.jamda.2023.06.025. Epub 2023 Jul 29. J Am Med Dir Assoc. 2023. PMID: 37527793 Review.
Cited by
-
Association of Retinal Nerve Fiber Layer Thinning With Elevated High Density Lipoprotein Cholesterol in UK Biobank.Invest Ophthalmol Vis Sci. 2024 Sep 3;65(11):12. doi: 10.1167/iovs.65.11.12. Invest Ophthalmol Vis Sci. 2024. PMID: 39240552 Free PMC article.
-
Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer's disease pathology in the eye clinic.Alzheimers Res Ther. 2024 Aug 21;16(1):190. doi: 10.1186/s13195-024-01545-1. Alzheimers Res Ther. 2024. PMID: 39169442 Free PMC article.
-
Risk of glaucoma to subsequent dementia or cognitive impairment: a systematic review and meta-analysis.Aging Clin Exp Res. 2024 Aug 20;36(1):172. doi: 10.1007/s40520-024-02811-w. Aging Clin Exp Res. 2024. PMID: 39162899 Free PMC article.
-
Acanthopanax senticosus improves cognitive impairment in Alzheimer's disease by promoting the phosphorylation of the MAPK signaling pathway.Front Immunol. 2024 Mar 13;15:1383464. doi: 10.3389/fimmu.2024.1383464. eCollection 2024. Front Immunol. 2024. PMID: 38545117 Free PMC article.
-
Thirty Risk Factors for Alzheimer's Disease Unified by a Common Neuroimmune-Neuroinflammation Mechanism.Brain Sci. 2023 Dec 31;14(1):41. doi: 10.3390/brainsci14010041. Brain Sci. 2023. PMID: 38248256 Free PMC article. Review.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
